Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2010 2
2011 16
2012 19
2013 30
2014 32
2015 21
2016 33
2017 33
2018 31
2019 23
2020 30
2021 29
2022 20
2023 31
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Results by year

Filters applied: . Clear all
Page 1
Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital.
Yoshihara F, Matsuzawa Y, Nakatsuka K, Kirigaya J, Takeuchi I, Kimura K, Konishi M, Tamura K, Fukui K, Tsukahara K, Shimizu H, Iwabuchi K, Yamada Y, Saka K, Sato Y, Ogawa M, Hayakawa K, Ohmagari N, Ikeda S, Akao M, Shimomura H, Kihara Y, Yoshimoto A, Morita M, Kumada N, Ogata S, Nishimura K, Arisato T, Matsuo M, Kishida M, Yasuda S, Ogawa H. Yoshihara F, et al. Hypertens Res. 2024 Apr 26. doi: 10.1038/s41440-024-01682-y. Online ahead of print. Hypertens Res. 2024. PMID: 38664510
ARB were divided into 1st- and 2nd-generations based on their approval for use (before 2000 and after 2001), with the former consisting of losartan, candesartan, and valsartan, and the latter of telmisartan, olmesartan, irbesartan, and azilsartan. The difference of ARB gen …
ARB were divided into 1st- and 2nd-generations based on their approval for use (before 2000 and after 2001), with the former consisting of l …
Azilsartan improves doxorubicin-induced cardiotoxicity via inhibiting oxidative stress, proinflammatory pathway, and apoptosis.
Al-Chlaihawi M, Janabi A. Al-Chlaihawi M, et al. J Med Life. 2023 Dec;16(12):1783-1788. doi: 10.25122/jml-2023-0106. J Med Life. 2023. PMID: 38585516 Free PMC article.
Azilsartan, a known angiotensin receptor blocker, has shown potential in reducing 24-hour blood pressure and may have protective effects against cardiac complications. Increased oxidative stress in cardiac tissue is directly related to the cardiac complications of doxorubi …
Azilsartan, a known angiotensin receptor blocker, has shown potential in reducing 24-hour blood pressure and may have protective effe …
Angiotensin II Is Involved in MLKL Activation During the Development of Heart Failure Following Myocardial Infarction in Rats.
Marunouchi T, Onda S, Kurasawa M, Tanonaka K. Marunouchi T, et al. Biol Pharm Bull. 2024;47(4):809-817. doi: 10.1248/bpb.b23-00741. Biol Pharm Bull. 2024. PMID: 38583954 Free article.
This increase in necroptotic cells was attenuated by pretreatment with azilsartan. Furthermore, activated MLKL was increased in cardiomyocytes cultured in conditioned medium. Pretreatment with azilsartan also prevented the conditioned medium-induced increase in acti …
This increase in necroptotic cells was attenuated by pretreatment with azilsartan. Furthermore, activated MLKL was increased in cardi …
Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea.
Kim H, Son N, Jeong D, Yoo M, Choi IY, Choi W, Chung YW, Ko SW, Byun S, Im S, Sim DW, Seo J, Kang MG, Lee JK, Seo YG, An HJ, Kim Y, Chae S, Jun DW, Chang DJ, Kim SG, Yi S, Yang HJ, Lee I, Park HJ, Lee JH, Kim B, Lee EE. Kim H, et al. Drug Saf. 2024 Mar 21. doi: 10.1007/s40264-024-01418-4. Online ahead of print. Drug Saf. 2024. PMID: 38512445
In 2021, the Korea Ministry of Food and Drug Safety acknowledged the need for national compensation for a drug-induced liver injury (DILI) after azilsartan use. However, little is known regarding the association between angiotensin receptor blockers and DILI. ...In monothe …
In 2021, the Korea Ministry of Food and Drug Safety acknowledged the need for national compensation for a drug-induced liver injury (DILI) a …
Azilsartan improves urinary albumin excretion in hypertension mice.
Cao J, Zhang D, Li W, Yuan W, Luo G, Xie S. Cao J, et al. Aging (Albany NY). 2024 Mar 10;16(5):4138-4148. doi: 10.18632/aging.205271. Epub 2024 Mar 10. Aging (Albany NY). 2024. PMID: 38462692 Free PMC article.
However, the effects of Azilsartan on urinary albumin excretion in hypertension haven't been reported before. ...Compared to the control group, the ANG/HS group had higher blood pressure, oxidative stress, and inflammatory response, all of which were rescued by Azilsart …
However, the effects of Azilsartan on urinary albumin excretion in hypertension haven't been reported before. ...Compared to the cont …
Protective effects of Azilsartan against cyclophosphamide-induced ovarian toxicity in rats model.
Mahmood NMA. Mahmood NMA. Toxicol Res (Camb). 2024 Mar 4;13(2):tfae027. doi: 10.1093/toxres/tfae027. eCollection 2024 Apr. Toxicol Res (Camb). 2024. PMID: 38450178
OBJECTIVES: So, this study aimed to evaluate the protective effects of Azilsartan (AZ) as an antioxidant and anti-inflammatory agent in a rat model of CP-induced ovarian toxicity. ...On the other hand, histopathological findings revealed that ovarian sections in animals th …
OBJECTIVES: So, this study aimed to evaluate the protective effects of Azilsartan (AZ) as an antioxidant and anti-inflammatory agent …
Renin-Angiotensin System Inhibitors Suppress the Growth of Leukemia Cells.
Itoh M, Sasaki S, Tohda S. Itoh M, et al. Anticancer Res. 2024 Mar;44(3):1183-1192. doi: 10.21873/anticanres.16913. Anticancer Res. 2024. PMID: 38423665
We used four RAS inhibitors: the renin inhibitor aliskiren, angiotensin-converting enzyme 1 inhibitor captopril, angiotensin II type 1 receptor antagonist azilsartan, and angiotensin II type 2 receptor antagonist PD123319. ...The expression of signaling proteins was assess …
We used four RAS inhibitors: the renin inhibitor aliskiren, angiotensin-converting enzyme 1 inhibitor captopril, angiotensin II type 1 recep …
Implication of endoplasmic reticulum stress and mitochondrial perturbations in remote liver injury after renal ischemia/reperfusion in rats: potential protective role of azilsartan.
Elrashidy RA, Zakaria EM, Hasan RA, Elmaghraby AM, Hassan DA, Abdelgalil RM, Abdelmohsen SR, Negm AM, Khalil AS, Eraque AMS, Ahmed RM, Sabbah WS, Ahmed AA, Ibrahim SE. Elrashidy RA, et al. Redox Rep. 2024 Dec;29(1):2319963. doi: 10.1080/13510002.2024.2319963. Epub 2024 Feb 27. Redox Rep. 2024. PMID: 38411133 Free PMC article.
This study aimed to elucidate the cross-talk of endoplasmic reticulum (ER) stress and mitochondrial perturbations in renal I/R-induced liver injury, and the potential hepatoprotective effect of azilsartan (AZL).Methods: Male albino Wister rats were pre-treated with AZL (3 …
This study aimed to elucidate the cross-talk of endoplasmic reticulum (ER) stress and mitochondrial perturbations in renal I/R-induced liver …
Effect of Azilsartan on clinical blood pressure reduction compared to other angiotensin receptor blockers: a systematic review and meta-analysis.
Khan QA, Sharma S, Mulk IU, Li D, Belay NF, Afzal M, Farrukh AM, Asad M, Baqi A, Semakieh B. Khan QA, et al. Ann Med Surg (Lond). 2023 Dec 8;86(2):958-967. doi: 10.1097/MS9.0000000000001547. eCollection 2024 Feb. Ann Med Surg (Lond). 2023. PMID: 38333313 Free PMC article. Review.
Higher doses of Azilsartan showed greater efficacy, with 80 mg exhibiting the most substantial reduction in SBP. The analysis emphasized the need for more studies investigating lower Azilsartan doses (10 and 20 mg). CONCLUSION: This systematic review and meta-analys …
Higher doses of Azilsartan showed greater efficacy, with 80 mg exhibiting the most substantial reduction in SBP. The analysis emphasi …
The Discovery of Novel Agents against Staphylococcus aureus by Targeting Sortase A: A Combination of Virtual Screening and Experimental Validation.
Liu K, Tong J, Liu X, Liang D, Ren F, Jiang N, Hao Z, Li S, Wang Q. Liu K, et al. Pharmaceuticals (Basel). 2023 Dec 29;17(1):58. doi: 10.3390/ph17010058. Pharmaceuticals (Basel). 2023. PMID: 38256891 Free article.
In this study, we combined virtual screening with experimental validation to identify potential drug candidates from a drug library. Three hits, referred to as Naldemedine, Telmisartan, and Azilsartan, were identified based on docking binding energy and the ratio of occupi …
In this study, we combined virtual screening with experimental validation to identify potential drug candidates from a drug library. Three h …
310 results